|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08225 C HEALTH GP
Nominal 
0.146 0.000 (0.000%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | -- | -- | 26,454 | 21,425 | 13,090 | 83,601 |
| Cost of Sales | -- | -- | (16,387) | (13,213) | (7,347) | (19,744) |
| Gross Profit | -- | -- | 10,067 | 8,212 | 5,743 | 63,857 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | (381) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | 18 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | -- | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | -- | -- | (14,473) | (58,211) | (15,826) | 42,521 | |
| Taxation | -- | -- | (46) | 0 | 0 | (6,196) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | -- | -- | 0 | 197 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (14,962) | 3.051% | (14,519) | (58,014) | (15,826) | 36,325 | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | -- | -- | (63) | (116) | (185) | (415) |
| Depreciation & Amortisation | -- | -- | 606 | 234 | 151 | 201 |
| Directors' Emoluments | -- | -- | 151 | 755 | 1,156 | 260 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified (Modified Report) | Qualified | Qualified | Qualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -1.500 | 2.740% | -1.460 | -5.830 | -1.590 | 3.650 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.010 | 0.001 | (0.005) | (0.010) |
| NBV per share ($) | -- | -- | 0.071 | 0.085 | 0.143 | 0.156 |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -14,962 |
| %Change | 3.051% |
| EPS / (LPS) | RMB -0.015 |
| NBV Per Share (¥) | RMB -- |